NCT00193076View on ClinicalTrials.gov

Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

October 31, 2008

Conditions

Breast Cancer

Interventions

DRUG

Gemcitabine

Gemcitabine

DRUG

Carboplatin

Carboplatin

DRUG

Trastuzumab

Trastuzumab

Trial Locations (1)

37203

Tennessee Oncology, Nashville

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER